← Eichor
Condition: Kidney Transplant Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Kidney Transplant Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT07347769Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
Phase N/A · 1 location(s) · Mahidol University · NCT06700876A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Phase N/A · 25 location(s) · Takeda · NCT06243731Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit fo
Phase 4 · 1 location(s) · University Hospital, Strasbourg, France · NCT06881927The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT05588492Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Phase 1/Phase 2 · 1 location(s) · University of California, San Diego · NCT06409819Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
Phase 2 · 1 location(s) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infe · NCT07197164Tacrolimus Pharmacokinetic Subpopulations
Phase N/A · 2 location(s) · University Hospital, Grenoble · NCT04526431Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections
Phase 3 · 5 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06334497Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Str
Phase 3 · 1 location(s) · University Hospital, Rouen · NCT05708508A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
Phase 3 · 13 location(s) · The University of Queensland · NCT05325008TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
NA · 4 location(s) · Hospices Civils de Lyon · NCT06829719Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Cent
NA · 1 location(s) · National Taiwan University Hospital · NCT07294547Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metasta
Phase 1/Phase 2 · 26 location(s) · National Cancer Institute (NCI) · NCT05896839Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive
Phase N/A · 1 location(s) · Tulane University · NCT05159466Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Dis
Phase 4 · 1 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT07266467Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
NA · 18 location(s) · Johns Hopkins University · NCT06263426Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Mult
Phase 3 · 9 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05597540Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989Double Voiding and Post-transplant UTI
NA · 1 location(s) · Weill Medical College of Cornell University · NCT05711446Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01644903A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative
Phase 3 · 71 location(s) · Pierre Fabre Medicament · NCT03394365Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Phase 3 · 1 location(s) · University of Wisconsin, Madison · NCT06407232A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney
Phase 1/Phase 2 · 31 location(s) · GlaxoSmithKline · NCT04006808Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
Phase 4 · 1 location(s) · University of Sao Paulo General Hospital · NCT06584773Shingrix in Renal Transplant Recipients
Phase 3 · 4 location(s) · University of Colorado, Denver · NCT04128189Immune Registry for BK in Kidney Transplant Recipients
Phase N/A · 1 location(s) · Virginia Commonwealth University · NCT06538961Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Phase 4 · 2 location(s) · Camille N. Kotton, MD · NCT06958796Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein B
Phase 4 · 1 location(s) · University Hospital, Strasbourg, France · NCT04989491Studies on Adsorption International Learning Initiative Global
NA · 1 location(s) · Botkin Hospital · NCT07123909
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.